December 14, 2024 17:08 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Pushpa 2 stampede: Allu Arjun walks out of jail, actor's lawyer slams delay in release | Donald Trump intends to end 'inconvenient' and 'very costly' Daylight Saving Time | Suchir Balaji: Indian-origin former OpenAI researcher found dead at US apartment | Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days
Merck's Covid pill Molnupiravir out of national treatment protocol for 'major safety concerns': ICMR

Merck's Covid pill Molnupiravir out of national treatment protocol for 'major safety concerns': ICMR

Jan 06, 2022, at 04:36 am

New Delhi/IBNS: Indian Council for Medical Research (ICMR) has cited 'major safety concerns' for not adding Merck's coronavirus pill, Molnupiravir, to the national treatment protocol.